Methods have been developed for the detection of exposure to carcinogens and other DNA damaging agents in experimental animals and man through the detection of carcinogens or their metabolic derivatives in body fluids, or through adducts bound covalently to DNA or hemoglobin. The successful use of urinary markers of genotoxic exposures has been reported with respect to nitrosoproline as an indicator of exposure to Nnitroso compounds. The same approach has been used to detect AFBI and AFB1-N7-Gua as markers of exposure to aflatoxin B,; of 3-methyladenine produced as a result of exposure to methylating agents; and thymine glycol as an indicator of exposure to agents causing oxidative damage to DNA. Detection of adducts formed between genotoxic agents and hemoglobin has been reported in studies of populations occupationally exposed to ethylene oxide, in which 3-hydroxyhistidine and 3-hydroxyvaline have been measured, and in smokers, whose hemoglobin has been found to contain levels of 4-aminobiphenyl and 3-hydroxyvaline that were correlated with the frequency of cigarette smoking.
Introduction
It is an honor to have been invited to participate in this symposium on "Scientific Advances in Environmental Health," especially since its purpose is to recognize the many contributions of Dr. Norton Nelson to the development of the modern field of environmental health sciences and to the founding of the Institute of Environmental Medicine. Through his wisdom, insight, creativity, organizational genius and inexhaustible energy, he has played a major role in the initiation and development of many aspects of environmental health science throughout the international scientific community. The In certain respects, the current status of the fleld of markers of carcinogen exposure represents a culmination of efforts to bring together current knowledge about mechanisms of carcinogenesis and mutagenesis and highly sophisticated analytical methods to detect molecular and cellular events that may be predictive of health risks. This is a very timely and important area of research endeavor, inasmuch as the process of risk assessment is finding increasing application by regulatory decisionmaking bodies in the process of formulating policies intended to minimize health risks resulting from exposure to hazardous substances. The process of risk assessment requires the use of factual data to define the health effects of exposure of individuals or of populations to such substances. By current definition, the process of risk assessment includes three elements: hazard identification, doseresponse assessment, and risk characterization. Exposure assessment and epidemiology data are key components of the dose-response assessment, the objective of which is to define dose-incidence relationships for adverse health effects (such as cancer) in human populations. These components, together with animal bioassay data, appropriate extrapolations of information concerning dose-effects in animals, and interspecies differences in response, effectively determine the quantitative features of the risk estimation and are therefore of critical importance.
Epidemiologic studies designed to evaluate the health significance of environmental chemicals, including carcinogens, are seriously compromised by the lack of quantitative exposure data for individuals in exposed populations. Monitoring data on levels of compounds in environmental media often represent the only information available, and average population exposure is therefore the only quantitative parameter that can be calculated. Biological monitoring, i.e., measurements that can be made on cells, tissues, or body fluids of exposed people, has the objective of defining "dose" (internal or biologically effective) on an individual basis. Information gained from such measurements has the potential for identifying potentially hazardous exposures before adverse health effects appear and also for establishing exposure limits for minimizing the likelihood of significant health risks. Because measurements are made on individuals, they provide an indication not only of exposure to a given substance, but also of the amount absorbed and metabolically transformed to activated derivatives, viz., the fraction bound to functionally important cellular sites. Biological monitoring data provide information complementary to that derived from analysis of environmental media, and because they can be interpreted in the context of known mechanisms of action, are more directly relevant to assessment of health risks. Exposure assessment strategies based on biological monitoring can therefore be designed to take into account exposures through multiple routes and integrate the The subjects of biological monitoring and its applications in the field that has come to be known as molecular epidemiology have been the subjects of several recent comprehensive reviews. This discussion will emphasize detection methodology and will summarize currently available inforrnation on carcinogen exposure. A broader perspective on the field can be found in several more comprehensive reviews (1) (2) (3) (4) (5) (6) (7) (8) Assessment of human exposure to aflatoxins through measurement of urinary excretion of the major DNA adduct has been reported in two studies. Groopman et al. (12) used the technique of immunoaffinity purification coupled with HPLC detection to identify the guanine adduct of aflaxtoxin B1 in the urine of persons residing in a commune in Guangxi Province of China, where independent evidence indicated that the dietary content of the carcinogen was high. The analytical method was adequately sensitive to detect the presence of the adduct in persons exposed at high levels, and also to quantify the excretion of aflatoxin Ml, a metabolite, as well as unmetabolized carcinogen. Aflatoxin exposure was also measured by urinary excretion of the guanine adduct in populations living in areas with different liver cancer incidence in Kenya by Autrup et al. (13) . The presence of the adduct was detected by HPLC used in combination with synchronous scanning fluorescence spectrophotometry, and it was detected in 12% of a large series (983) of samples collected over a period of years in different areas of the country. Both analytical methods require sophisticated analytical instrumentation and are not yet applicable for routine monitoring.
Two additional approaches based on analysis of urinary components are being developed as potential monitors for exposure to genotoxic exposures. Shuker et al. (14) have explored the measurement of 3-methyl adenine in urine as an indicator of exposure to methylating agents. As indicated in Table 1 , they have developed a GC-MS method using single ion monitoring capable of detecting the methylated base in nominally unexposed individuals. Further validation of the method will be required to determine its usefulness as an exposure monitor. Cathcart et al. (15) used an HPLC assay for determining levels of free thymine glycol and thymidine glycol in urine, as a noninvasive assay for oxidative DNA damage, since these compounds are products of DNA damage caused by ionizing radiation and other oxidative mutagens. While they were able to determine excretion rates for both compounds in healthy individuals, the method is very labor intensive and time consuming, and in its present form has found only limited application.
Hemoglobin Adducts
A summary of representative data on measurements of hemoglobin adducts derived from exposure to carcinogens is presented in Table 2 . Most of the work done to date has concerned the measurement of N-3-(2-hydroxyethyl)histidine (HEH) or hydroxyethylvaline (HV) as monitors of exposure to ethylene oxide. This methodology, in which the alkylated derivative was measured by GC-MS, was developed by Ehrenberg and his colleagues, and was used in the study of occupationally exposed workers (16) . Average data shown in Table 2 for exposed subjects and unexposed controls indicate the sensitivity of the method for detecting exposure. Other findings in this study indicated the general agreement of the data obtained in man with those predicted from earlier studies in the mouse and also demonstrated the superiority of the method for providing a cumulative measure of exposure as compared to point monitoring of air levels.
The same methodology was subsequently applied by Van Sittert et al. (17) in a study of workers in an ethylene oxide manufacturing plant, in which cytogenetic and immunologic end points were made simultaneously in the same individuals. These investigators reported a substantially higher background of HEH in their control subjects and reported no significant difference between exposed and unexposed persons. Farmer et al. (18) compared levels of HEH, as determined by GC-MS on protein hydrolysates in which the adduct was concentrated by ion exchange chromatography, with levels of HV determined by GC-MS analysis of hemoglobin subjected to Edman degradation before analysis. They found that the two methods of analysis gave consistent results, especially at high levels, and also that higher levels of background alkylation (of unknown origin) were obtained in measurements of HEH than with HV, suggesting that the latter assay would show greater sensitivity in monitoring exposure to ethylene oxide. This method was subsequently applied in a study of cigarette smokers and nonsmokers (19) . The results demonstrated an elevation of HV levels in smokers that was quantitatively compatible with measured levels of ethylene in the smoke to which they were exposed.
Bryant et al. (20) have developed a method for the analysis of 4-aminobiphenyl covalently bound as the sulfinic acid amide to the 93-beta cysteine of human hemoglobin. The method involves hydrolysis of the hemoglobin followed by GC-MS determination of the parent amine after derivatization. Application of the method to smokers and nonsmokers revealed consistently elevated levels in smokers and also a detectable background of the adduct in nonsmokers of undetennined origin. Collectively, these results indicate the applicability of analysis of hemoglobin adducts as monitors of exposure to carcinogens of different structural types and mode of action.
Detection of BPDE Adducts in DNA by Immunoassay or Chemical Analysis
Several studies have been conducted to date that were designed to determine exposure to the ubiquitous polycyclic aromatic hydrocarbon benzo[a]pyrene (BaP) through the detection of derivatives covalently bound to DNA. Immunoassays and physicochemical methods have been applied to detect derivatives formed through the major intermediate in the activation pathway, the benzo[alpyrene-7,8-diol-9,10-epoxide (BPDE). Immunoassays have been applied in two modes, enzyme-linked immunosorbent assay, (ELISA) and ultrasensitive enzyme radioimmunoassay (USERIA), both employing polyclonal antisera that recognize BPDE-DNA adducts, with various levels of cross-reactivity with structurally related congeners. In an early pilot study in humans, Perera et al. (21) demonstrated that the ELISA assay was sufficiently sensitive to detect adducts in the DNA extracted from lung tumors as well as from nontumor tissue in lung cancer patients, but the small number of subjects studied precluded conclusions concerning exposure history.
Shamsuddin et al. (22) employed ELISA and USERIA assays to investigate the levels of BPDE-DNA adducts in the white blood cells (WBC) of roofers and foundry workers, in view of their exposure to high levels of BaP. Adducts were detected in a significant proportion of exposed individuals and also in 2/9 control subjects, both of whom were cigarette smokers. The technique of synchronous scanning fluorimetric spectrophotometry (SSFS) was applied in the analysis of DNA of WBC collected from workers in an aluminum plant for the presence of BPDE-DNA adducts (23) . The limit of detection of this method as applied is about one adduct in 107 nucleotides. One sample of WBC DNA from the series of 30 exposed subjects showed the presence of a detectable level of BPDE.
Harris et al. (24) analyzed the DNA of WBC of coke oven workers by USERIA and by SSFS to determine the frequency and levels of BPDE adducts as markers of ex-posure, as these workers are known to be exposed to high levels of BaP and are also at an elevated risk of lung cancer. Approximately two-thirds of the workers had detectable levels of BPDE-DNA adducts as determined by immunoassay, and an even larger proportion showed spectral evidence of the presence of BPDE by the SSFS assay. Antibodies to the DNA adducts were also detected in the serum of 27% of the workers. Coke oven workers were also the subjects of a study by Haugen et al. (25) , who sought to evaluate the genotoxic effects of their occupational exposures through a study of BPDE-DNA adducts with simultaneous measurements of urinary excretion of PAH metabolites and air monitoring. As in the earlier study, DNA adducts were measured by USERIA and SSFS, and the sera were examined for the presence of anti-DNA adduct antibodies. The Adduct levels were also higher in samples from people living in the high risk areas. DNA adducts induced by the anticancer drug cis-diamminechloroplatinum (II) were detected in the WBC of cancer patients treated with the drug through application of ELISA methodology (28) . The immunoassay procedure used four antisera capable of detecting different adducts, including intrastrand cross-links on pGpG sequences (which proved to be the major adduct); intrastrand cross-links on pApG sequences; inter-or intrastrand cross-links on two guanines separated by one or more bases; or monofunctional adducts bound to guanine. Results indicated that the susceptibility of WBC to adduct formation can show strong individually determined differences.
Reed et al. (29) also used ELISA methodology to study adducts derived from cis-platinum in WBC of ovarian cancer patients being treated with the drug. Values for median adduct levels were grouped by complete response (CR), partial response (PR), and no response (NR), and statistical analysis of the data showed that higher level of adduct formation correlated with clinical responsiveness to the drug.
These data show that adducts formed in DNA of acces- Detection of Aromatic DNA Adducts by 32P-Postlabeling
The postlabeling procedure developed by Randerath and his collaborators has been extensively applied to studies of DNA adduct formation in a variety of experimental systems, and the ability of the methodology to detect adducts of a large number of carcinogens (about 50) has been reported. The procedure has recently been extended to studies in humans, with results that can be summarized as follows. Everson et al. (30) investigated the presence of DNA adducts in human term placentas by both ELISA and by the 32P-postlabeling assay. The immunoassay revealed a small but insignificant increase in BPDE adduct levels in placentas from smokers compared to nonsmokers. However, the postlabeling assay detected a number of adduct types, the major one being strongly related to maternal smoking during pregnancy. Subsequently, Randerath et al. (31) compared adduct levels in human bronchus and larynx from smokers with those produced in mouse skin treated with cigarette tar. The human tissues were found to contain detectable levels of adducts, one of which (designated adduct 1) was identical to a major and persistent adduct formed in mouse skin. Dunn and Stich (32) used the postlabeling assay to investigate DNA adducts in exfoliated mucosal cells collected from the oral cavity of three groups at high risk for oral cancer. Five chromatographically distinct adducts were found in both the high risk groups and nonsmoking controls. Individual adducts were detected in 30 to 90% of the samples, and no adducts were found in high risk groups that did not also appear in control groups. Thus, although the method was successful in detecting adducts derived from unknown sources, it did not differentiate between exposed and nonexposed populations.
Using the same approach, Chacko and Gupta (33) analyzed the DNA from oral mucosal cells of cigarette smokers and nonsmokers to determine whether smokingrelated adducts could be identified. Two chromatographically distinct adducts of unknown identity were found in smokers but not in nonsmokers. In addition, the levels of these major and several minor adducts were substantially higher in smokers. Phillips et al. (34) 
DNA Adducts and Hemoglobin Adducts as Measures of Exposure and Susceptibility
The information summarized previously provides valuable evidence concerning some features of currently available methodologies for detecting and quantifying covalent adducts to DNA and hemoglobin in human material. The data show that detecting exposure to carcinogens of a variety of chemical types is feasible using methods currently available or being developed. Substantial additional technological refinement and validation will be required before any of the current methods will be routinely applicable in large-scale epidemiologic studies. However, it seems likely that many of them will eventually come into broader application. In interpreting the data generated by their application, it is important to take into account all pertinent information concerning the parameters being measured. 
